刘尧 川北医学院附属第二医院,四川绵阳四〇四医院 | 服务评价当时收到审稿人的回复,说我的语言存在逻辑问题,然后我朋友就建议我在LetPub润色,我当时也没有找到其他的润色机构,就把文章给LetPub了,文章修改的很仔细,整篇文章的语言都做了修改,最后提交到了 Cancer Management and Research 网站,很快就接受了,很感谢LetPub,我的第二篇文章也是在LetPub润色的,也被接受了,还在排版,等网上可以搜索了,再来写评论。修改范例文章已发表在SCI期刊 Cancer Management and Research(最新中科院SCI期刊分区:4区),标题为: Gastrointestinal Stromal Tumors of the Small Intestine: Progress in Diagnosis and Treatment Research(点击链接可查看全文)发表时间:2021-01-25 16:03:26 |
查看更多反馈:首页 上一页 1 下一页 尾页 共1条,1页 |
客户发表文章致谢近期发表在SCI期刊《Cancer Management and Research》的文章(最新中科院SCI期刊分区:4区),标题为: Influence of CDK5 Regulatory Subunit-Associated Protein 1-Like 1 Expression on the Survival of Patients with Non-Metastatic Nasopharyngeal Carcinoma(点击链接可查看全文),在Acknowledgments部分提We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.----------Zhanzhan Li, Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, People’s Republic of China | |
客户发表文章致谢近期发表在SCI期刊《Cancer Manag Res》的文章(最新中科院SCI期刊分区:4区),标题为: Differentiation of Treatment-Related Effects from Glioma Recurrence Using Machine Learning Classifiers Based Upon Pre-and Post-Contrast T1WI and T2(点击链接可查看全文),在Acknowledgments部分提We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.-----Xin-Yi Gao, Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, People’s Republic of China | |
客户发表文章致谢近期发表在SCI期刊《Cancer Management and Research》的文章(最新中科院SCI期刊分区:4区),标题为: miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway(点击链接可查看全文),在Acknowledgments部分提We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.-----Jiafu Zhao, College of Life Science, Guizhou University, Guiyang 550025, People’s Republic of China; | |
客户发表文章致谢近期发表在SCI期刊《Cancer Management and Research》的文章(最新中科院SCI期刊分区:4区),标题为: The Clinical Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Brain Metastases from Non–Small Cell Lung Cancer-Harboring EGFR Mutations(点击链接可查看全文),在Acknowledgments部分提We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.-----Hongwei Li, Department of Radiotherapy, Shanxi Medical University, Shanxi Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China | |
客户发表文章致谢近期发表在SCI期刊《Cancer Management and Research》的文章(最新中科院SCI期刊分区:4区),标题为: Apatinib for Treatment of Inoperable Metastatic or Locally Advanced Chondrosarcoma: What We Can Learn About the Biological Behavior of Chondrosarcoma from a Two-Center Study(点击链接可查看全文),在Acknowledgments部分提We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.-----Lu Xie, Musculoskeletal Tumor Center, Peking University People’s Hospital, Beijing, People’s Republic of China; | |
客户发表文章致谢近期发表在SCI期刊《Cancer Management and Research》的文章(最新中科院SCI期刊分区:4区),标题为: Development and External Validation of a Nomogram to Predict Cancer-Specific Survival in Patients with Primary Intestinal Non-Hodgkin Lymphomas(点击链接可查看全文),在Acknowledgments部分提We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.----------Cuifen Zhang, The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of T | |
客户发表文章致谢近期发表在SCI期刊《Cancer management and research》的文章(最新中科院SCI期刊分区:4区),标题为: Adenosquamous carcinoma of the bile duct: a population-based study(点击链接可查看全文),在Acknowledgments部分提We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.----------Qin, Bao-Dong, Department of Medical Oncology, Changzheng Hospital, Second Military Medical University, Shanghai, China | |
查看更多反馈:首页 上一页 1 下一页 尾页 共8条,1页 |
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室